AstraZeneca wins EU approval of Axanum for CV prevention in those at gastric risk
02 August 2011
Pial Ganguli
Please Login to read the full article.
02 August 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pozen criticises partner AZ as it vows to make aspirin/PPI combo affordable
- Pozen looking to US submission in 2H 2012 for secondary CV prevention drug
- Pozen gains after positive PIII results for ulcer reducing aspirin, as partner search gains momentum
- J&J/Bayer to pursue secondary CV prevention in ACS label for Xarelto
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
